Valeritas today priced its upcoming initial public offering, looking to raise $52.5 million through the sale of 5.25 million shares at $10 per share. The offering includes a 30-day underwriters option for the purchase of an additional 787,500 shares, which would take the total funding possible in the round to approximately $60 million. Bridgewater, N.J.-based Valeritas makes […]
Funding Roundup
Tandem Diabetes Care prices $22.5m public offering
Tandem Diabetes Care (NSDQ:TNDM) today announced the pricing details of a $22.5 million underwritten public offering. The company priced 18 million shares of its common stock at $1.25 apiece. Tandem also gave underwriters a 30-day option to buy up to an additional 2.7 million shares of common stock at the public offering price. The offering is expected […]
Valeritas raises IPO stakes, looks for $60m
Valeritas this week raised the stakes for its upcoming initial public offering, looking to raise $60 million by floating 6 million shares at between $9 and $11, up from an earlier hoped for $50 million. Bridgewater, N.J.-based Valeritas makes the V-Go basal insulin delivery system for Type II diabetes, a fully disposable, continuous-delivery device that’s designed to […]
Ivenix pulls down $10m tranche in $50m round
Ivenix raised $10 million in equity from 18 unnamed investors in the 1st tranche of its $50 million round, according to regulatory filings. The company indicated that it does not expect the offering to exceed 1 year. It has not made a formal statement about how it plans to spend the newly-acquired funds. The Massachusetts-based start-up […]
Penumbra prices $99m offering
Penumbra (NYSE:PEN) said today that it priced a public offering worth nearly $99 million, not including an underwriter’s option worth nearly $15 million. Alameda, Calif.-based Penumbra makes a line of instruments designed for neurovascular and peripheral vascular procedures, including stroke revascularization, embolization and thrombectomy. The company said it plans to float 1.3 million shares at $76 […]
Robotic arm brace maker Myomo looks for $15m in Regulation A+ IPO
Myomo said today it is looking to raise up to $15 million in a Regulation A+ initial public offering and gain listing on the New York Stock Exchange MKT. The Cambridge, Mass.-based company is taking advantage of new federal securities law under the Jumpstart Our Business Startups Act passed under Obama, which allow small private companies to […]
AliveCor raises $30m, launches Kardia Pro platform in U.S.
AliveCor said today that it landed $30 million in a series D funding round and that it released its artificial intelligence-enabled Kardia Pro platform in the U.S. The company’s platform enables doctors to remotely monitor their patients for early signs of atrial fibrillation, a common cardiac arrhythmia. “Heart disease is the No. 1 cause of death […]
Visioneering Technologies closes $26m IPO
Visioneering Technologies Inc said today it closed a $25.5 million (AUD $33.3 million) initial public offering in Australia, with funds slated to support its NaturalVue multifocal contact lenses. In the offering, the Alpharetta, Ga.-based company floated approximately 79.4 million shares of Class A common stock at 32¢ (AUD 42¢) per share, with strong support from Australian […]
Cohero Health oversubscribes Series A for connected respiratory tech
Cohero Health said today that it oversubscribed its $9 million Series A round with investments from Samsung Next and Omron Healthcare The latest contributions will be used to support commercialization of hardware and software for its BreatheSmart connected respiratory disease management platform, the N.Y.-based company said. Get the full story at our sister site, Drug Delivery Business News.
Active Implants lands first $10m of $40m Series D round
Active Implants said today that it banked the 1st $10 million tranche of its $40 million Series D round. New backer LS Health Science Partners led the round with the 1st tranche and is due to put up another $20 million, with the remaining $10 million slated to come from existing investors, the Memphis-based company said. Active […]
RenalGuard reels in $15m Series A
RenalGuard Solutions said today that it raised a $14.5 million Series A round for a pivotal trial of its device to prevent acute kidney injury during percutaneous procedures. The Milford, Mass.-based company’s eponymous device is designed to measure urine output and automatically infuse hydration fluid based on those measurements. It aims to induce high urine rates to protect […]